Novel inhibitors of the PI3K family

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.18, Iss.9, 2009-09, pp. : 1265-1277

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Computational Medicinal Chemistry to Design Novel Phosphoinositide 3- Kinase (PI3K) Alpha Inhibitors in View of Cancer

Current Bioactive Compounds, Vol. 10, Iss. 3, 2014-08 ,pp. : 147-157

Bentham Science Publishers

Access to resources Recommend Favorite

PI3K/Akt Signalling Pathway Specific Inhibitors: A Novel Strategy to Sensitize Cancer Cells to Anti-Cancer Drugs

Current Pharmaceutical Design, Vol. 16, Iss. 12, 2010-04 ,pp. : 1410-1416

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and Biological Activity of Akt/PI3K Inhibitors

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 10, 2006-10 ,pp. : 1127-1136

Bentham Science Publishers

Access to resources Recommend Favorite

Between Bench and Bed Side: PI3K Inhibitors

Current Molecular Pharmacology, Vol. 3, Iss. 2, 2010-06 ,pp. : 79-90

Bentham Science Publishers

Access to resources Recommend Favorite

PI3K/AKT/mTOR Inhibitors In Ovarian Cancer

Current Medicinal Chemistry, Vol. 17, Iss. 36, 2010-12 ,pp. : 4433-4447

Bentham Science Publishers

Access to resources Recommend Favorite